or Try an Advanced Search...

    Technical Analysis for TRAW - Traws Pharma, Inc.

    Grade Last Price % Change Price Change
    F 0.66 1.48% 0.01
    TRAW closed down 1.99 percent on Wednesday, May 8, 2024, on 25 percent of normal volume.
    Earnings due: May 13
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical TRAW trend table...
    Date Alert Name Type % Chg
    Spinning Top Other -0.54%
    NR7 Range Contraction -0.54%
    Narrow Range Bar Range Contraction -0.54%
    Gapped Up Strength -0.54%
    MACD Bullish Signal Line Cross Bullish 2.96%
    Inside Day Range Contraction 2.96%
    Wide Bands Range Expansion 3.77%
    Gapped Up Strength 3.77%
    Outside Day Range Expansion 2.87%
    Wide Bands Range Expansion 2.87%
    Older End-of-Day Signals for TRAW ...

       Recent Intraday Alerts

    Alert Time
    Up 1% 19 minutes ago
    10 DMA Support about 22 hours ago
    60 Minute Opening Range Breakdown about 23 hours ago
    Down 3% about 23 hours ago
    Fell Below 10 DMA about 23 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    TRAW Chart by TradingView
    Basic chart:

    Profile

    Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer

    Is TRAW a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 4 Traws Pharma Full Year 2023 Earnings: Beats Expectations
    Apr 2 Onconova slips after all-stock merger with Trawsfynydd
    Apr 2 Traws Pharma Announces New Employee Inducement Grants
    Apr 2 Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
    Dec 12 Onconova stock falls 10% on preclinical data for lymphoma drug
    Dec 12 Onconova Therapeutics’ Narazaciclib ASH Poster Highlights Activity in Treatment Resistant Mantle Cell Lymphoma
    Dec 8 Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s
    Nov 28 Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
    Nov 16 Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2023 Earnings Call Transcript
    Nov 15 Onconova Therapeutics, Inc. (ONTX) Q3 2023 Earnings Call Transcript
    See more TRAW news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.33
    52 Week Low 0.5509
    Average Volume 139,990
    200-Day Moving Average 0.76
    50-Day Moving Average 0.80
    20-Day Moving Average 0.67
    10-Day Moving Average 0.64
    Average True Range 0.05
    RSI (14) 42.20
    ADX 27.92
    +DI 11.86
    -DI 23.39
    Chandelier Exit (Long, 3 ATRs) 0.69
    Chandelier Exit (Short, 3 ATRs) 0.76
    Upper Bollinger Bands 0.74
    Lower Bollinger Band 0.59
    Percent B (%b) 0.37
    BandWidth 22.47
    MACD Line -0.04
    MACD Signal Line -0.05
    MACD Histogram 0.0052
    Fundamentals Value
    Market Cap 13.66 Million
    Num Shares 21 Million
    EPS -0.96
    Price-to-Earnings (P/E) Ratio -0.68
    Price-to-Sales 64.59
    Price-to-Book 1.01
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.71
    Resistance 3 (R3) 0.71 0.69 0.70
    Resistance 2 (R2) 0.69 0.67 0.69 0.69
    Resistance 1 (R1) 0.67 0.66 0.66 0.67 0.69
    Pivot Point 0.65 0.65 0.65 0.65 0.65
    Support 1 (S1) 0.63 0.64 0.62 0.63 0.61
    Support 2 (S2) 0.61 0.63 0.61 0.61
    Support 3 (S3) 0.59 0.61 0.60
    Support 4 (S4) 0.59